XBRU:MITRA (Belgium)  
Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

€ 6.32 (+1.12%) Sep 30
P/E:
At Loss
P/B:
8.85
Market Cap:
€ 337.21M ($ 330.63M)
Enterprise V:
€ 528.01M ($ 517.70M)
Volume:
55.52K
Avg Vol (2M):
124.43K
Also Trade In:
Volume:
55.52K
Market Cap €:
337.21M
Market Cap $:
330.63M
PE Ratio:
At Loss
Avg Vol (2-Month):
124.43K
Enterprise Value €:
528.01M
Enterprise Value $:
517.70M
PB Ratio:
8.85
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its lead development candidates include Estelle and donesta. Its geographical segments are Europe and Outside Europe.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.08
Debt-to-Equity 6.09
Debt-to-EBITDA -3.27
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.41
Distress
Grey
Safe
Beneish M-Score -1.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 35.97
9-Day RSI 38.49
14-Day RSI 40.65
6-1 Month Momentum % -42.7
12-1 Month Momentum % -62.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.8
Quick Ratio 0.42
Cash Ratio 0.23
Days Inventory 1098.65
Days Sales Outstanding 170.94
Days Payable 533.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.4

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 21.883
EPS (TTM) (€) -2.1
Beta 1
Volatility % 42.28
14-Day RSI 40.65
14-Day ATR (€) 0.329951
20-Day SMA (€) 6.714
12-1 Month Momentum % -62.54
52-Week Range (€) 5.95 - 22.1
Shares Outstanding (Mil) 53.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mithra Pharmaceuticals SA Filings

Document Form Filing Date
No Filing Data

Mithra Pharmaceuticals SA Analysis

Share your research